DAPK1 and epilepsy: Targeted inhibition of DAPK1 decreases neural activity, ameliorates inflammatory responses, prevents gliosis, reduces apoptosis, and promotes the recovery of cognition, thus exerting neuroprotective and therapeutic effects on epilepsy.